Insider Transactions in Q3 2023 at Kinnate Biopharma Inc. (KNTE)
Insider Transaction List (Q3 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 01
2023
|
Richard Thomas Williams CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
541
-0.78%
|
$1,082
$2.35 P/Share
|
Sep 01
2023
|
Mark A Meltz COO GENERAL COUNSEL SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
541
-1.85%
|
$1,082
$2.35 P/Share
|
Sep 01
2023
|
Neha Krishnamohan CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,459
-2.13%
|
$2,918
$2.35 P/Share
|